Literature DB >> 25694636

The successful use of lipectomy in the management of airway obstruction in a woman with HIV-associated lipodystrophy.

Edison Tsui1, Ronald Bogdasarian1, Eric Blomain1.   

Abstract

Lipodystrophy is a common complication of highly active antiretroviral therapy and is associated with significant comorbidities. Altered fat distribution, particularly lipohypertrophy of the dorsal cervical fat pad is associated with reduced quality of life as well as medical complications. We report the rare case of a patient with airway obstruction secondary to HIV-associated lipodystrophy. Ultrasound-assisted liposuction was successfully performed to relieve her airway obstruction and to facilitate a tracheostomy. To the best of our knowledge, this is the first documented case of its kind. We also provide a brief review of the literature on the current management options for HIV-associated lipodystrophy. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25694636      PMCID: PMC4336867          DOI: 10.1136/bcr-2014-208053

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  24 in total

1.  Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial.

Authors:  Véronique Joly; Philippe Flandre; Vincent Meiffredy; Nicolas Leturque; Marine Harel; Jean-Pierre Aboulker; Patrick Yeni
Journal:  AIDS       Date:  2002-12-06       Impact factor: 4.177

2.  Use of ultrasonography-assisted liposuction for the treatment of human immunodeficiency virus-associated enlargement of the dorsocervical fat pad.

Authors:  P J Piliero; M Hubbard; J King; J J Faragon
Journal:  Clin Infect Dis       Date:  2003-10-13       Impact factor: 9.079

3.  Suction-assisted lipectomy for lipodystrophy.

Authors:  Nancy Connolly; Ernest Manders; Sharon Riddler
Journal:  AIDS Res Hum Retroviruses       Date:  2004-08       Impact factor: 2.205

4.  Management options for facial lipoatrophy.

Authors:  Joseph Cofrancesco; Todd Brown; Ciro R Martins
Journal:  AIDS Read       Date:  2004-12

5.  Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine.

Authors:  Cesar Fisac; Emilio Fumero; Manuel Crespo; Beatriz Roson; Elena Ferrer; Nuria Virgili; Esteban Ribera; Jose Maria Gatell; Daniel Podzamczer
Journal:  AIDS       Date:  2005-06-10       Impact factor: 4.177

6.  Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides.

Authors:  Michael P Dubé; Robert A Parker; Pablo Tebas; Steven K Grinspoon; Robert A Zackin; Gregory K Robbins; Ronenn Roubenoff; Robert W Shafer; David A Wininger; William A Meyer; Sally W Snyder; Kathleen Mulligan
Journal:  AIDS       Date:  2005-11-04       Impact factor: 4.177

7.  Surgical management of HIV-associated lipodystrophy: role of ultrasonic-assisted liposuction and suction-assisted lipectomy in the treatment of lipohypertrophy.

Authors:  C Scott Hultman; Lindsee E McPhail; Jeffrey H Donaldson; David A Wohl
Journal:  Ann Plast Surg       Date:  2007-03       Impact factor: 1.539

8.  Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients.

Authors:  Susan D Driscoll; Gary E Meininger; Mark T Lareau; Sara E Dolan; Kathleen M Killilea; Colleen M Hadigan; Donald M Lloyd-Jones; Anne Klibanski; Walter R Frontera; Steven K Grinspoon
Journal:  AIDS       Date:  2004-02-20       Impact factor: 4.177

9.  Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study.

Authors:  Grace A McComsey; Douglas J Ward; Siegrid M Hessenthaler; Michael G Sension; Peter Shalit; J Tyler Lonergan; Robin L Fisher; Vanessa C Williams; Jaime E Hernandez
Journal:  Clin Infect Dis       Date:  2003-12-18       Impact factor: 9.079

10.  Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.

Authors:  Julian Falutz; Diane Potvin; Jean-Claude Mamputu; Hani Assaad; Monika Zoltowska; Sophie-Elise Michaud; Daniel Berger; Michael Somero; Graeme Moyle; Stephen Brown; Claudia Martorell; Ralph Turner; Steven Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2010-03       Impact factor: 3.731

View more
  1 in total

1.  Clinical outcome after lipectomy in the management of patients with human immunodeficiency virus-associated dorsocervical fat accumulation: An observational cohort study.

Authors:  Song Chen; Xi-En Gui; Qian Cao; Jean-Pierre Routy
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.